These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20351388)

  • 1. Vascular complications after percutaneous coronary intervention following hemostasis with the Mynx vascular closure device versus the AngioSeal vascular closure device.
    Azmoon S; Pucillo AL; Aronow WS; Ebrahimi R; Vozzolo J; Rajdev A; Kalapatapu K; Ro JH; Hjemdahl-Monsen C
    J Invasive Cardiol; 2010 Apr; 22(4):175-8. PubMed ID: 20351388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular closure devices--the other side of hemostasis.
    Ghitelman J; Garcia LA
    J Invasive Cardiol; 2010 Apr; 22(4):179-80. PubMed ID: 20351389
    [No Abstract]   [Full Text] [Related]  

  • 3. Active Versus Passive Anchoring Vascular Closure Devices Following Percutaneous Coronary Intervention: A Safety and Efficacy Comparative Analysis.
    Baker NC; Escarcega RO; Lipinski MJ; Magalhaes MA; Koifman E; Kiramijyan S; Negi SI; Torguson R; Waksman R
    J Interv Cardiol; 2016 Feb; 29(1):108-12. PubMed ID: 26728544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity matched analysis of bleeding and vascular complications associated with vascular closure devices vs standard manual compression following percutaneous coronary intervention.
    Iqtidar AF; Li D; Mather J; McKay RG
    Conn Med; 2011 Jan; 75(1):5-10. PubMed ID: 21329285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient tolerance and resource utilization associated with an arterial closure versus an external compression device after percutaneous coronary intervention.
    Juergens CP; Leung DY; Crozier JA; Wong AM; Robinson JT; Lo S; Kachwalla H; Hopkins AP
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):166-70. PubMed ID: 15390237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of angiographic femoral artery complications after vascular closure with Mynx and AngioSeal.
    Fargen KM; Velat GJ; Lawson MF; Ritchie CA; Firment C; Hoh BL; Bennett JA; Mocco J
    J Neurointerv Surg; 2013 Mar; 5(2):161-4. PubMed ID: 22266794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Success, Safety, and Efficacy of the Mynx Femoral Closure Device in a Real-World Cohort: Single-Center Experience.
    Hutchings D; Hayat A; Karunakaran A; Malik N
    J Invasive Cardiol; 2016 Mar; 28(3):104-8. PubMed ID: 26945253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of the Angioseal device for femoral artery closure.
    Abando A; Hood D; Weaver F; Katz S
    J Vasc Surg; 2004 Aug; 40(2):287-90. PubMed ID: 15297822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of complications following sheath removal with percutaneous coronary intervention.
    Sulzbach-Hoke LM; Ratcliffe SJ; Kimmel SE; Kolansky DM; Polomano R
    J Cardiovasc Nurs; 2010; 25(3):E1-8. PubMed ID: 20357666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute evaluation of the Mynx vascular closure device during arterial re-puncture in an ovine model.
    Garasic JM; Marin L; Anderson RD
    J Invasive Cardiol; 2009 Jun; 21(6):283-5. PubMed ID: 19494406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular complications with newer generations of angioseal vascular closure devices.
    Applegate RJ; Sacrinty M; Kutcher MA; Gandhi SK; Baki TT; Santos RM; Little WC
    J Interv Cardiol; 2006 Feb; 19(1):67-74. PubMed ID: 16483343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angioseal VIP® vs. StarClose SE® closure devices: a comparative analysis in non-cardiological procedures.
    Lucatelli P; Fanelli F; Cannavale A; Corona M; Cirelli C; D'Adamo A; Salvatori FM; Catalano C
    J Cardiovasc Surg (Torino); 2017 Feb; 58(1):80-86. PubMed ID: 24309473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bleeding complications using arterial closure device versus manual compression by propensity matching in patients undergoing percutaneous coronary intervention.
    Allen DS; Marso SP; Lindsey JB; Kennedy KF; Safley DM
    Am J Cardiol; 2011 Jun; 107(11):1619-23. PubMed ID: 21420052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro).
    Chamberlin JR; Lardi AB; McKeever LS; Wang MH; Ramadurai G; Grunenwald P; Towne WP; Grassman ED; Leya FS; Lewis BE; Stein LH
    Catheter Cardiovasc Interv; 1999 Jun; 47(2):143-7; discussion 148. PubMed ID: 10376492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of peripheral vascular complications associated with the use of percutaneous suture-mediated closure devices.
    Sprouse LR; Botta DM; Hamilton IN
    J Vasc Surg; 2001 Apr; 33(4):688-93. PubMed ID: 11296318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Arterial Closure Devices in an Office-Based Angiosuite.
    Jones LE; Yang KH; Feldtman RW; Uceda PV; Ferrara CA; Caruso JM; Richmond JL; Ahn SS
    Ann Vasc Surg; 2018 Aug; 51():10-17. PubMed ID: 29655814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized single-blind trial of patient comfort following vessel closure: extravascular synthetic sealant closure provides less pain than a self-tightening suture vascular compression device.
    Fargen KM; Hoh BL; Mocco J
    J Neurointerv Surg; 2011 Sep; 3(3):219-23. PubMed ID: 21990828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients.
    Eggebrecht H; Haude M; Woertgen U; Schmermund A; von Birgelen C; Naber C; Baumgart D; Kaiser C; Oldenburg O; Bartel T; Kroeger K; Erbel R
    Catheter Cardiovasc Interv; 2002 Dec; 57(4):486-95. PubMed ID: 12455083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful reduction of surgeries secondary to arterial access site complications: a retrospective review at a single center with an extravascular closure device.
    Noor S; Meyers S; Curl R
    Vasc Endovascular Surg; 2010 Jul; 44(5):345-9. PubMed ID: 20484072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mynx Vascular Closure Device in Arterial Endovascular Procedures.
    Scott MC; Spencer HJ; Ali AT; Moursi MM; Escobar GA; Lyons LC; Smeds MR
    Ann Vasc Surg; 2018 Jan; 46():112-117. PubMed ID: 28546043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.